Join the Ischemic Stroke group to help and get support from people like you.
Ischemic Stroke News (Page 10)
Related terms: Cerebrovascular Accident (CVA), Stroke, CVA, Cerebrovascular Accident, Stroke, ischemic
Sleep Changes Common for Stroke Survivors
THURSDAY, Sept. 12, 2024 – Less than half of people who've survived a stroke will go on to have a healthy, normal sleep pattern, new research shows. Normal sleep is defined as six to eight hours of...
Black Stroke Patients More Likely to Arrive Late at Hospital, Without Prior ER Notification
THURSDAY, Sept. 12, 2024 – Black stroke victims are arriving at emergency rooms much later than white patients, greatly increasing their risk of death or lifelong disability, a new study finds....
A-Fib May Be 3 Times More Common Than Thought
THURSDAY, Sept. 12, 2024 – The number of Americans with a potentially dangerous heart rhythm condition is three times greater than previously thought, a new study claims. An estimated 5% of the...
Stroke Survivors More Likely to Have Abnormal Sleep Duration
THURSDAY, Sept. 12, 2024 – U.S. stroke survivors are more likely to have abnormal sleep duration when compared with individuals who have not had a stroke, according to a study published online Sept....
Adjunctive IV Argatroban, Eptifibatide Do Not Cut Disability After Stroke
FRIDAY, Sept. 6, 2024 – Adjunctive treatment with intravenous argatroban or eptifibatide does not reduce poststroke disability among patients with acute ischemic stroke treated with intravenous...
Balloon Angioplasty Lowers Risk for Composite Outcome in Intracranial Artery Stenosis
FRIDAY, Sept. 6, 2024 – For patients with symptomatic intracranial atherosclerotic stenosis (sICAS), balloon angioplasty plus aggressive medical management is associated with a lower risk for a...
Wearable Heart Monitor Ups Detection of A-fib by More Than 50%
WEDNESDAY, Sept. 4, 2024 – A wearable heart monitor raises the detection rate of the dangerous irregular heartbeat known as atrial fibrillation (A-fib) by more than 50%, a new study finds....
Low-Frequency rTMS Improves Urinary Incontinence After Stroke
TUESDAY, Sept. 3, 2024 – Four weeks of low-frequency repeated transcranial magnetic stimulation (rTMS) positively impacts poststroke urinary incontinence, according to a study published online Aug....
Endometriosis Linked to Higher Heart Risks for Women
MONDAY, Sept 2, 2024 – Endometriosis can be a painful, debilitating condition for many women, but new research suggests even more serious consequences: higher odds for heart attacks or strokes....
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find
FRIDAY, Aug.30, 2024 – New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of...
Black Patients Less Likely to Receive Diagnostic Testing in Emergency Department
WEDNESDAY, Aug. 28, 2024 – Black patients are less likely than White patients with a nonspecific diagnosis of interest to receive related diagnostic testing in the emergency department, according to...
Wegovy Helps Patients With Heart Failure Avoid Heart Attack, Stroke
FRIDAY, Aug. 23, 2024 – Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart attacks and strokes, and now more data from the...
Brilinta Approved in the US to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
6 November 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic str...
FDA Approves Praluent (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization
PARIS and TARRYTOWN, NY – April 26, 2019 – The U.S. Food and Drug Administration (FDA) has approved Praluent (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina requiring hos...
FDA Medwatch Alert: Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
ISSUE: An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart...